What is Proteome Sciences plc (PMSNF)?

Proteome Sciences plc (PMSNF) is a stock in the Healthcare sector, Medical - Specialties industry. View full analysis on Stocks360.

What is the current price of PMSNF?

The current price of PMSNF is $0.01. Prices are updated in real time on Stocks360.

What is PMSNF's price-to-earnings (PE) ratio?

PMSNF's trailing twelve-month PE ratio is -2.00, based on current price and earnings per share data available on Stocks360.

What is PMSNF's market capitalization?

PMSNF's market capitalization is $2,889,231.00, placing it in the small-cap tier.

Proteome Sciences plc (PMSNF)

Stock analysis · OTC · Healthcare · Medical - Specialties

$0.01

Market Cap

$2.89M

PE (TTM)

-2.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.15

Day Range

$0.01 – $0.01

52-wk Range

$0.01 – $0.04

Avg Volume

N/A

Volume

4.00K

Proteome Sciences plc (PMSNF) is a publicly traded company in the Healthcare sector. Latest price: $0.01. Market cap $2.89M. Trailing PE -2.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-30 · $0.03 2026-10-29 · $0.01 (-66.67%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Proteome Sciences plc

Proteome Sciences Plc is a provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. It offers proprietary technologies for protein and peptide biomarker discovery, validation, and assay development. The company focuses on developing proprietary protein biomarkers for neurological diseases, oncology, and organ transplant rejection. Proteome Sciences was founded on December 10, 1993 and is headquartered in Cobham, the United Kingdom.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-2.00×
P/S (TTM)	1.36×
P/B	-0.50×
P/FCF (TTM)	13.95×
EV / EBITDA	-15.41×
EV / Sales	5.30×
Earnings Yield	-46.34%
Free Cash Flow Yield	7.17%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$19.97M
Revenue (TTM)	$3.77M
Net Income (TTM)	-$2.37M
Free Cash Flow (TTM)	$1.04M
Net Debt	$14.85M
Working Capital	-$14.73M
Gross Margin	-25.36%
Operating Margin	-60.56%
Net Margin	-61.46%
Return on Equity	23.85%
Return on Invested Capital	-25.45%